Variant report
Variant | esv3356431 |
---|---|
Chromosome Location | chr2:76697346-76714281 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149574129 | chr2:76697381-76697382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117029261 | chr2:76697390-76697391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112349689 | chr2:76697409-76697410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1921241 | chr2:76697425-76697426 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs545916349 | chr2:76697439-76697440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564001343 | chr2:76697485-76697486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143231439 | chr2:76697505-76697506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547688759 | chr2:76697512-76697513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148385209 | chr2:76697514-76697515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142222076 | chr2:76697560-76697561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73938120 | chr2:76697562-76697563 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs569750621 | chr2:76697627-76697628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537026280 | chr2:76697839-76697840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184089113 | chr2:76697856-76697857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116469073 | chr2:76697878-76697879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535078909 | chr2:76697947-76697948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs58642088 | chr2:76697949-76697950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574683328 | chr2:76697978-76697979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542183356 | chr2:76697993-76697994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367637668 | chr2:76698018-76698019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11126524 | chr2:76698034-76698035 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs375371962 | chr2:76698048-76698049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146371570 | chr2:76698051-76698052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs11680215 | chr2:76698079-76698080 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs34763136 | chr2:76698080-76698081 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs139661259 | chr2:76698091-76698092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140076395 | chr2:76698106-76698107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374980298 | chr2:76698107-76698108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540275081 | chr2:76698111-76698112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142469527 | chr2:76698131-76698132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs17012738 | chr2:76698142-76698143 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs73938121 | chr2:76698161-76698162 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs570036622 | chr2:76698164-76698165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531204339 | chr2:76698197-76698198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs36005302 | chr2:76698240-76698241 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs570781102 | chr2:76698244-76698245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534854841 | chr2:76698272-76698273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35412086 | chr2:76698277-76698278 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs568294173 | chr2:76698278-76698279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535621318 | chr2:76698305-76698306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557161340 | chr2:76698329-76698330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11126525 | chr2:76698353-76698354 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs576735186 | chr2:76698377-76698378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187693276 | chr2:76698421-76698422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373502163 | chr2:76698482-76698483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539989909 | chr2:76698493-76698494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139514116 | chr2:76698522-76698523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs573374682 | chr2:76698524-76698525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116079000 | chr2:76698584-76698585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149677159 | chr2:76698606-76698607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:76694800-76705800 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr2:76698800-76699000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr2:76700200-76701200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:76700600-76701400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr2:76701200-76705400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:76704800-76705000 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr2:76704800-76706600 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr2:76705000-76706000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr2:76705000-76706200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr2:76705200-76706000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr2:76705400-76706200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr2:76705400-76706200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr2:76705600-76706000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr2:76705600-76706400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr2:76705800-76706000 | Enhancers | Fetal Muscle Leg | muscle |
16 | chr2:76705800-76706200 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr2:76707200-76707400 | Enhancers | Fetal Muscle Leg | muscle |